Theorem Clinical Research Expands its Cardiovascular Expertise Through Alliance With BioTelemetry

KING OF PRUSSIA, Pa.--()--Theorem Clinical Research, a leading clinical research organization specializing in complex trials, has announced the formation of a strategic alliance with BioTelemetry, Inc. (Nasdaq: BEAT). BioTelemetry's Clinical Research division includes Cardiocore, a leading, global cardiac core laboratory.

"Theorem's business strategy is to offer our clients the very best in every service area," said John Potthoff, Theorem president and CEO. "BioTelemetry reinforces that strategy with a team of industry-leading scientists, a set of advanced technologies and a broad base of cardiac testing modalities. Theorem clients will benefit from BioTelemetry's expert consulting services and deep experience across all major therapeutic areas."

BioTelemetry CEO Joseph Capper noted, "Theorem's experience in complex protocols aligns perfectly with our specialized cardiovascular testing services. The partnership complements BioTelemetry's unique position that spans from clinical research through post-market surveillance and into clinical practice. Both companies support trials in all clinical phases of pharmaceutical and biotech development and will collaborate globally within this alliance."

"Trends in the industry such as safety monitoring boards, translational medicine and risk-based monitoring put additional pressures on the clinical trial process to be faster, safer and more efficient," said Potthoff. "Our strategic partnership with BioTelemetry allows us to meet — and exceed — those industry standards for our clients."

About Theorem Clinical Research
Theorem Clinical Research Inc. is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of the world's top pharmaceutical, biotech and medical device companies. As a forerunner in medical device and drug-device combination trials with notable capabilities in pharmaceuticals and biologics, Theorem offers deep expertise in a broad range of therapeutic areas and in all phases of development. With some of the industry's top scientists and most advanced clinical analytics capabilities, Theorem ensures smooth-running, successful trials. For the full-service, right-size global research partner, don't think twice. THINK THEOREM.

Suggested Articles

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.